{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:15:36Z","timestamp":1791400536744,"version":"4.3.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Ulm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Preclinical studies provided convincing evidence that umbilical cord derived mesenchymal stem cells (UC-MSC) prevent lung injury and promote lung regeneration. We hypothesized that cyclic mechanical stretch (CMS) and hyperoxia (HOX) during mechanical ventilation account for their limited therapeutic efficacy within the clinics. UC-MSC cultures were subjected to CMS and HOX and evaluated for proliferation, cell viability and further functional properties. Reversibility of the phenotype changes was evaluated after recovery in room air following these exposures. CMS and HOX compromised cell viability and proliferation, altered phenotypic characteristics, particularly PDGFR\u03b1 expression, and induced cellular senescence in UC-MSC. Effects were most pronounced for CMS plus HOX. The alterations of UC-MSC were mediated by p21 accumulation. As inhibition of p21 aggravated cell death of UC-MSC, the results indicated a cell defense mechanism to ensure survival. This assumption was underpinned by the principal reversibility of the phenotype alterations and regrowth after removal of CMS and HOX. But prolonged strongest exposures resulted in definite phenotype changes. CMS and HOX have comparable effects on UC-MSC as described for lung resident MSC. Our results explain their timely limited presence in the diseased lung after therapeutic application. Future research should therefore focus on their repetitive application.<\/jats:p>","DOI":"10.1038\/s41598-025-22330-6","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T19:40:25Z","timestamp":1759866025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Phenotype disruption of umbilical cord derived MSC by cyclic mechanical stretch and hyperoxia mediated by p21"],"prefix":"10.1038","volume":"15","author":[{"given":"Maurizio J.","family":"Goetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Behnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Oehmke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Holzfurtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Korte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Rivetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Bellusci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Ehrhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"22330_CR1","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1007\/s12015-023-10539-9","volume":"19","author":"G Yang","year":"2023","unstructured":"Yang, G. et al. Immunomodulatory mechanisms and therapeutic potential of mesenchymal stem cells. Stem cell. Reviews Rep. 19, 1214\u20131231 (2023).","journal-title":"Stem cell. Reviews Rep."},{"issue":"4","key":"22330_CR2","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.3390\/ijms24043376","volume":"24","author":"M Jerkic","year":"2023","unstructured":"Jerkic, M., Szaszi, K., Laffey, J. G., Rotstein, O. & Zhang, H. Key role of mesenchymal stromal cell interaction with macrophages in promoting repair of lung injury. Int. J. Mol. Sci. 24(4), 3376.  https:\/\/doi.org\/10.3390\/ijms24043376 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"22330_CR3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","volume":"7","author":"DM Hoang","year":"2022","unstructured":"Hoang, D. M. et al. Stem cell-based therapy for human diseases. Signal. Transduct. Target. Therapy. 7, 272 (2022).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"22330_CR4","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s13287-022-03054-0","volume":"13","author":"R Margiana","year":"2022","unstructured":"Margiana, R. et al. Clinical application of mesenchymal stem cell in regenerative medicine: A narrative review. Stem Cell Res. Ther. 13, 366 (2022).","journal-title":"Stem Cell Res. Ther."},{"key":"22330_CR5","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1007\/s12015-021-10314-8","volume":"18","author":"A Sharma","year":"2022","unstructured":"Sharma, A., Gupta, S., Archana, S. & Verma, R. S. Emerging trends in mesenchymal stem cells applications for cardiac regenerative therapy: Current status and advances. Stem cell. Reviews Rep. 18, 1546\u20131602 (2022).","journal-title":"Stem cell. Reviews Rep."},{"key":"22330_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-022-00932-0","volume":"7","author":"Y Han","year":"2022","unstructured":"Han, Y. et al. The secretion profile of mesenchymal stem cells and potential applications in treating human diseases. Signal. Transduct. Target. Therapy. 7, 92 (2022).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"22330_CR7","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/cvr\/cvab135","volume":"118","author":"R Bolli","year":"2022","unstructured":"Bolli, R., Solankhi, M., Tang, X. L. & Kahlon, A. Cell therapy in patients with heart failure: A comprehensive review and emerging concepts. Cardiovascular. Res. 118, 951\u2013976 (2022).","journal-title":"Cardiovascular. Res."},{"key":"22330_CR8","doi-asserted-by":"publisher","first-page":"152041","DOI":"10.1016\/j.acthis.2023.152041","volume":"125","author":"J Gopalarethinam","year":"2023","unstructured":"Gopalarethinam, J., Nair, A. P., Iyer, M., Vellingiri, B. & Subramaniam, M. D. Advantages of mesenchymal stem cell over the other stem cells. Acta Histochem. 125, 152041 (2023).","journal-title":"Acta Histochem."},{"key":"22330_CR9","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3390\/jcm9030682","volume":"9","author":"J Behnke","year":"2020","unstructured":"Behnke, J. et al. MSC based therapies-new perspectives for the injured lung. J. Clin. Med. 9, 682 (2020).","journal-title":"J. Clin. Med."},{"key":"22330_CR10","doi-asserted-by":"publisher","first-page":"151724","DOI":"10.1016\/j.semperi.2023.151724","volume":"47","author":"B Th\u00e9baud","year":"2023","unstructured":"Th\u00e9baud, B. Stem cell therapies for neonatal lung diseases: Are we there yet? Semin. Perinatol. 47, 151724 (2023).","journal-title":"Semin. Perinatol."},{"key":"22330_CR11","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.3390\/ijms22031138","volume":"22","author":"MJ Goetz","year":"2021","unstructured":"Goetz, M. J. et al. MSC based therapies to prevent or treat BPD-A narrative review on advances and ongoing challenges. International J. Mol. Sciences 22, 1138 (2021).","journal-title":"International J. Mol. sciences"},{"key":"22330_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13287-023-03287-7","volume":"14","author":"A Lotfy","year":"2023","unstructured":"Lotfy, A., AboQuella, N. M. & Wang, H. Mesenchymal stromal\/stem cell (MSC)-derived exosomes in clinical trials. Stem Cell Res. Ther. 14, 66 (2023).","journal-title":"Stem Cell Res. Ther."},{"key":"22330_CR13","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.stemcr.2021.05.003","volume":"16","author":"SJ Sun","year":"2021","unstructured":"Sun, S. J., Wei, R., Li, F., Liao, S. Y. & Tse, H. F. Mesenchymal stromal cell-derived exosomes in cardiac regeneration and repair. Stem cell. Rep. 16, 1662\u20131673 (2021).","journal-title":"Stem cell. Rep."},{"key":"22330_CR14","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.12659\/MSM.910316","volume":"24","author":"J Jiang","year":"2018","unstructured":"Jiang, J., Song, Z. & Zhang, L. miR-155-5p promotes progression of acute respiratory distress syndrome by inhibiting differentiation of bone marrow mesenchymal stem cells to alveolar type II epithelial cells. Med. Sci. Monitor: Int. Med. J. Experimental Clin. Res. 24, 4330\u20134338 (2018).","journal-title":"Med. Sci. Monitor: Int. Med. J. Experimental Clin. Res."},{"key":"22330_CR15","first-page":"4625","volume":"22","author":"YQ Wu","year":"2018","unstructured":"Wu, Y. Q. & Ding, Y. J. Overexpressed microRNA-615-3p promotes progression of neonatal acute respiratory distress syndrome by inhibiting differentiation of mesenchymal stem cells to alveolar type II epithelial cells. Eur. Rev. Med. Pharmacol. Sci. 22, 4625\u20134633 (2018).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"22330_CR16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-020-0064-x","volume":"19","author":"EA Kimbrel","year":"2020","unstructured":"Kimbrel, E. A. & Lanza, R. Next-generation stem cells - ushering in a new era of cell-based therapies. Nat. Rev. Drug Discov. 19, 463\u2013479 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"22330_CR17","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1002\/sctm.17-0126","volume":"6","author":"S Augustine","year":"2017","unstructured":"Augustine, S. et al. Mesenchymal stromal cell therapy in bronchopulmonary dysplasia: Systematic review and meta-analysis of preclinical studies. Stem Cells Translational Med. 6, 2079\u20132093 (2017).","journal-title":"Stem Cells Translational Med."},{"key":"22330_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1089\/scd.2019.0116","volume":"29","author":"M O\u2019Reilly","year":"2020","unstructured":"O\u2019Reilly, M. et al. Late rescue therapy with cord-derived mesenchymal stromal cells for established lung injury in experimental bronchopulmonary dysplasia. Stem. Cells. Dev. 29, 364\u2013371 (2020).","journal-title":"Stem. Cells. Dev."},{"key":"22330_CR19","doi-asserted-by":"publisher","first-page":"e0183741","DOI":"10.1371\/journal.pone.0183741","volume":"12","author":"P Khedoe","year":"2017","unstructured":"Khedoe, P. et al. Acute and chronic effects of treatment with mesenchymal stromal cells on LPS-induced pulmonary inflammation, emphysema and atherosclerosis development. PloS One. 12, e0183741 (2017).","journal-title":"PloS One"},{"key":"22330_CR20","doi-asserted-by":"publisher","first-page":"761338","DOI":"10.3389\/fmicb.2021.761338","volume":"12","author":"J You","year":"2021","unstructured":"You, J., Fu, Z. & Zou, L. Mechanism and potential of extracellular vesicles derived from mesenchymal stem cells for the treatment of infectious diseases. Front. Microbiol. 12, 761338 (2021).","journal-title":"Front. Microbiol."},{"key":"22330_CR21","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1038\/s41467-023-39958-5","volume":"14","author":"Y Gao","year":"2023","unstructured":"Gao, Y. et al. Multi-omics analysis of human mesenchymal stem cells shows cell aging that alters Immunomodulatory activity through the downregulation of PD-L1. Nat. Commun. 14, 4373 (2023).","journal-title":"Nat. Commun."},{"key":"22330_CR22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/s13287-023-03587-y","volume":"14","author":"J Li","year":"2023","unstructured":"Li, J. et al. The heterogeneity of mesenchymal stem cells: An important issue to be addressed in cell therapy. Stem Cell Res. Ther. 14, 381 (2023).","journal-title":"Stem Cell Res. Ther."},{"key":"22330_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13036-023-00361-9","volume":"17","author":"VV Maldonado","year":"2023","unstructured":"Maldonado, V. V. et al. Clinical utility of mesenchymal stem\/stromal cells in regenerative medicine and cellular therapy. J. Biol. Eng. 17, 44 (2023).","journal-title":"J. Biol. Eng."},{"key":"22330_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13287-023-03286-8","volume":"14","author":"Q Liu","year":"2023","unstructured":"Liu, Q. et al. Efficacy and safety of human umbilical cord-derived mesenchymal stem cells for COVID-19 pneumonia: A meta-analysis of randomized controlled trials. Stem Cell Res. Ther. 14, 118 (2023).","journal-title":"Stem Cell Res. Ther."},{"key":"22330_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13054-022-04287-4","volume":"27","author":"F Wang","year":"2023","unstructured":"Wang, F., Li, Y., Wang, B., Li, J. & Peng, Z. The safety and efficacy of mesenchymal stromal cells in ARDS: A meta-analysis of randomized controlled trials. Crit. Care. (London, England). 27, 31 (2023).","journal-title":"Crit. Care. (London, England)"},{"key":"22330_CR26","doi-asserted-by":"publisher","first-page":"1072257","DOI":"10.3389\/fimmu.2022.1072257","volume":"13","author":"DJ Weiss","year":"2022","unstructured":"Weiss, D. J. & Rolandsson Enes, S. MSCs interaction with the host lung microenvironment: An overlooked aspect? Front. Immunol. 13, 1072257 (2022).","journal-title":"Front. Immunol."},{"key":"22330_CR27","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s13287-022-02985-y","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Mesenchymal stem cells and their microenvironment. Stem Cell Res. Ther. 13, 429 (2022).","journal-title":"Stem Cell Res. Ther."},{"key":"22330_CR28","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.75053","volume":"11","author":"C Dave","year":"2022","unstructured":"Dave, C. et al. Comparison of freshly cultured versus cryopreserved mesenchymal stem cells in animal models of inflammation: A pre-clinical systematic review. eLife 11, e75053 (2022).","journal-title":"eLife"},{"key":"22330_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fimmu.2012.00297","volume":"3","author":"E Eggenhofer","year":"2012","unstructured":"Eggenhofer, E. et al. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front. Immunol. 3, 297 (2012).","journal-title":"Front. Immunol."},{"key":"22330_CR30","doi-asserted-by":"publisher","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","volume":"7","author":"MM Lalu","year":"2012","unstructured":"Lalu, M. M. et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): A systematic review and meta-analysis of clinical trials. PloS One. 7, e47559 (2012).","journal-title":"PloS One"},{"key":"22330_CR31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13287-018-1043-6","volume":"9","author":"HA Poggio","year":"2018","unstructured":"Poggio, H. A. et al. Impact of one versus two doses of mesenchymal stromal cells on lung and cardiovascular repair in experimental emphysema. Stem Cell Res. Ther. 9, 296 (2018).","journal-title":"Stem Cell Res. Ther."},{"key":"22330_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41420-024-02073-5","volume":"10","author":"T Shahzad","year":"2024","unstructured":"Shahzad, T. et al. Anti-CCL2 therapy reduces oxygen toxicity to the immature lung. Cell. Death Discov. 10, 311 (2024).","journal-title":"Cell. Death Discov."},{"key":"22330_CR33","doi-asserted-by":"publisher","first-page":"L95","DOI":"10.1152\/ajplung.00367.2022","volume":"325","author":"J Waiden","year":"2023","unstructured":"Waiden, J. et al. Prenatal vitamin D supplementation mitigates inflammation-related alveolar remodeling in neonatal mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 325, L95\u2013L103 (2023).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"22330_CR34","doi-asserted-by":"publisher","first-page":"606678","DOI":"10.3389\/fmed.2021.606678","volume":"8","author":"L Amarelle","year":"2021","unstructured":"Amarelle, L., Quintela, L., Hurtado, J. & Malacrida, L. Hyperoxia and lungs: What we have learned from animal models. Front. Med. 8, 606678 (2021).","journal-title":"Front. Med."},{"key":"22330_CR35","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00355.2023","author":"J Behnke","year":"2024","unstructured":"Behnke, J. et al. Senescence of lung mesenchymal stem cells of preterm infants by cyclic stretch and hyperoxia via p21. Am. J. Physiol. Lung Cell. Mol. Physiol. https:\/\/doi.org\/10.1152\/ajplung.00355.2023 (2024).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"22330_CR36","doi-asserted-by":"publisher","DOI":"10.3791\/55224","author":"N Beeravolu","year":"2017","unstructured":"Beeravolu, N. et al. Isolation and characterization of mesenchymal stromal cells from human umbilical cord and fetal placenta. J. Visualized Exp. JoVE. https:\/\/doi.org\/10.3791\/55224 (2017).","journal-title":"J. Visualized Exp. JoVE"},{"key":"22330_CR37","doi-asserted-by":"publisher","first-page":"L87","DOI":"10.1152\/ajplung.00505.2017","volume":"315","author":"T Reicherzer","year":"2018","unstructured":"Reicherzer, T. et al. Activation of the NF-\u03baB pathway alters the phenotype of MSCs in the tracheal aspirates of preterm infants with severe BPD. Am. J. Physiol. Lung Cell. Mol. Physiol. 315, L87\u2013L101 (2018).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"22330_CR38","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1164\/rccm.202403-0569OC","volume":"211","author":"C Cyr-Depauw","year":"2025","unstructured":"Cyr-Depauw, C. et al. Single-Cell RNA sequencing to guide autologous preterm cord mesenchymal stromal cell therapy. Am. J. Respir. Crit Care Med. 211, 391\u2013406 (2025).","journal-title":"Am. J. Respir. Crit Care Med."},{"key":"22330_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","volume":"22","author":"R Di Micco","year":"2021","unstructured":"Di Micco, R., Krizhanovsky, V., Baker, D. &  Di d\u2019adda Fagagna, F. Cellular senescence in ageing: From mechanisms to therapeutic opportunities. Nat. Rev. Mol. Cell Biol. 22, 75\u201395 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"22330_CR40","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.trsl.2021.01.008","volume":"233","author":"J Bl\u00e1zquez-Prieto","year":"2021","unstructured":"Bl\u00e1zquez-Prieto, J. et al. Activation of p21 limits acute lung injury and induces early senescence after acid aspiration and mechanical ventilation. Translational Research: J. Lab. Clin. Med. 233, 104\u2013116 (2021).","journal-title":"Translational Research: J. Lab. Clin. Med."},{"key":"22330_CR41","doi-asserted-by":"publisher","first-page":"L525","DOI":"10.1152\/ajplung.00067.2019","volume":"317","author":"K You","year":"2019","unstructured":"You, K. et al. Moderate hyperoxia induces senescence in developing human lung fibroblasts. Am. J. Physiol. Lung Cell. Mol. Physiol. 317, L525\u2013L536 (2019).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"22330_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1165\/rcmb.2018-0410TR","volume":"61","author":"S Hamsanathan","year":"2019","unstructured":"Hamsanathan, S. et al. Cellular senescence: The Trojan horse in chronic lung diseases. Am. J. Respir. Cell Mol. Biol. 61, 21\u201330 (2019).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"22330_CR43","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/stcltm\/szac004","volume":"11","author":"Z Weng","year":"2022","unstructured":"Weng, Z. et al. Mesenchymal stem\/stromal cell senescence: Hallmarks, mechanisms, and combating strategies. Stem Cells Translational Med. 11, 356\u2013371 (2022).","journal-title":"Stem Cells Translational Med."},{"key":"22330_CR44","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.15252\/emmm.201607308","volume":"9","author":"P Oak","year":"2017","unstructured":"Oak, P. et al. Attenuated PDGF signaling drives alveolar and microvascular defects in neonatal chronic lung disease. EMBO Mol. Med. 9, 1504\u20131520 (2017).","journal-title":"EMBO Mol. Med."},{"key":"22330_CR45","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S0092-8674(00)81270-2","volume":"85","author":"H Bostr\u00f6m","year":"1996","unstructured":"Bostr\u00f6m, H. et al. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell 85, 863\u2013873 (1996).","journal-title":"Cell"},{"key":"22330_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40348-022-00137-z","volume":"9","author":"L Holzfurtner","year":"2022","unstructured":"Holzfurtner, L. et al. When inflammation meets lung development-an update on the pathogenesis of bronchopulmonary dysplasia. Mol. Cell. Pediatr. 9, 7 (2022).","journal-title":"Mol. Cell. Pediatr."},{"key":"22330_CR47","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13287-023-03374-9","volume":"14","author":"MS Kahrizi","year":"2023","unstructured":"Kahrizi, M. S. et al. Recent advances in pre-conditioned mesenchymal stem\/stromal cell (MSCs) therapy in organ failure; a comprehensive review of preclinical studies. Stem Cell Res. Ther. 14, 155 (2023).","journal-title":"Stem Cell Res. Ther."},{"key":"22330_CR48","doi-asserted-by":"publisher","first-page":"C1562","DOI":"10.1152\/ajpcell.00221.2010","volume":"299","author":"SM Chacko","year":"2010","unstructured":"Chacko, S. M. et al. Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. Am. J. Physiol. Cell Physiol. 299, C1562\u2013C1570 (2010).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"22330_CR49","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1165\/rcmb.2023-0038OC","volume":"70","author":"X Jing","year":"2024","unstructured":"Jing, X. et al. Cellular senescence contributes to the progression of hyperoxic bronchopulmonary dysplasia. Am. J. Respir. Cell Mol. Biol. 70, 94\u2013109 (2024).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"22330_CR50","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1165\/rcmb.2003-0049OC","volume":"30","author":"SA McGrath-Morrow","year":"2004","unstructured":"McGrath-Morrow, S. A., Cho, C., Soutiere, S., Mitzner, W. & Tuder, R. The effect of neonatal hyperoxia on the lung of p21Waf1\/Cip1\/Sdi1-deficient mice. Am. J. Respir. Cell Mol. Biol. 30, 635\u2013640 (2004).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"22330_CR51","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41419-021-03950-y","volume":"12","author":"Y Cao","year":"2021","unstructured":"Cao, Y. et al. ZFP36 protects lungs from intestinal I\/R-induced injury and fibrosis through the CREBBP\/p53\/p21\/Bax pathway. Cell Death Dis. 12, 685 (2021).","journal-title":"Cell Death Dis."},{"key":"22330_CR52","doi-asserted-by":"publisher","first-page":"L602","DOI":"10.1152\/ajplung.00441.2018","volume":"317","author":"RSJ Sarker","year":"2019","unstructured":"Sarker, R. S. J. et al. CARM1 regulates senescence during airway epithelial cell injury in COPD pathogenesis. Am. J. Physiol. Lung Cell. Mol. Physiol. 317, L602\u2013L614 (2019).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22330-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22330-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22330-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:02:13Z","timestamp":1760256133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22330-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22330"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22330-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experiments on human UC-MSC in this manuscript conform to the principles outlined in the declaration of Helsinki. All experiments were approved by the ethics committee of the Justus-Liebig-University Gie\u00dfen, Germany, (title \u201ccharacterization of changes in the tracheal aspirates of preterm infants (PROTECT-AIRR study)\u201c, protocol number Az. 135\/12, with amendment 5 approved 2020\/07\/08). Written informed consent was obtained from the parents of all participating infants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"35031"}}